| Mitochondrial localization of estrogen receptor β SH Yang, R Liu, EJ Perez, Y Wen, SM Stevens Jr, T Valencia, ... Proceedings of the National Academy of Sciences 101 (12), 4130-4135, 2004 | 576 | 2004 |
| Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles MMK Shahzad, LS Mangala, HD Han, C Lu, J Bottsford-Miller, ... Neoplasia 13 (4), 309-IN8, 2011 | 252 | 2011 |
| Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection L Prokai, K Prokai-Tatrai, P Perjesi, AD Zharikova, EJ Perez, R Liu, ... Proceedings of the National Academy of Sciences 100 (20), 11741-11746, 2003 | 222 | 2003 |
| A strategy for delivering peptides into the central nervous system by sequential metabolism N Bodor, L Prokai, WM Wu, H Farag, S Jonalagadda, M Kawamura, ... Science 257 (5077), 1698-1700, 1992 | 176 | 1992 |
| Targeting drugs to the brain by redox chemical delivery systems L Prokai, K Prokai‐Tatrai, N Bodor Medicinal research reviews 20 (5), 367-416, 2000 | 175 | 2000 |
| Mitochondria play a central role in estrogen-induced neuroprotection JW Simpkins, J Wang, X Wang, E Perez, L Prokai, JA Dykens Current Drug Targets-CNS & Neurological Disorders 4 (1), 69-83, 2005 | 151 | 2005 |
| Mechanisms of 4-hydroxy-2-nonenal induced pro-and anti-apoptotic signaling P Chaudhary, R Sharma, A Sharma, R Vatsyayan, S Yadav, SS Singhal, ... Biochemistry 49 (29), 6263-6275, 2010 | 139 | 2010 |
| Lanthionine− somatostatin analogs: synthesis, characterization, biological activity, and enzymatic stability studies G Ösapay, L Prokai, HS Kim, KF Medzihradszky, DH Coy, G Liapakis, ... Journal of medicinal chemistry 40 (14), 2241-2251, 1997 | 127 | 1997 |
| Serotonin in migraine: theories, animal models and emerging therapies S Ren, EJ Lien, NC Turner, JC Clapham, L Prokai, RTE Wagey, C Krieger, ... Progress in drug research, 219-244, 1998 | 118 | 1998 |
| Electrospray ionization mass spectrometry coupled with size‐exclusion chromatography L Prokai, WJ Simonsick Jr Rapid communications in mass spectrometry 7 (9), 853-856, 1993 | 118 | 1993 |
| Hydroxy metabolites of the Alzheimer's drug candidate 3-[(2, 4-dimethoxy) benzylidene]-anabaseine dihydrochloride (GTS-21): their molecular properties, interactions with brain … WR Kem, VM Mahnir, L Prokai, RL Papke, X Cao, S LeFrancois, ... Molecular pharmacology 65 (1), 56-67, 2004 | 117 | 2004 |
| Cholinergic neurons in the basal forebrain promote wakefulness by actions on neighboring non-cholinergic neurons: an opto-dialysis study JC Zant, T Kim, L Prokai, S Szarka, J McNally, JT McKenna, C Shukla, ... Journal of Neuroscience 36 (6), 2057-2067, 2016 | 111 | 2016 |
| HDL particles for delivery of nucleic acids AK Sood, AG Lacko, G Lopez-Berestein, LS Mangala, WJ McConathy, ... US Patent 8,734,853, 2014 | 111 | 2014 |
| Pleiotropic mechanisms of ribavirin antiviral activities N Seiler, B Duranton, F Raul, Z Hong, CE Cameron, J Hong Hu, C Krieger, ... Progress in drug research, 41-69, 2002 | 109 | 2002 |
| Gel permeation chromatography coupled to Fourier transform mass spectrometry for polymer characterization DJ Aaserud, L Prokai, WJ Simonsick Analytical chemistry 71 (21), 4793-4799, 1999 | 109 | 1999 |
| Field desorption mass spectrometry L Prokai CRC Press, 1989 | 105 | 1989 |
| Structure–nongenomic neuroprotection relationship of estrogens and estrogen-derived compounds L Prokai, JW Simpkins Pharmacology & therapeutics 114 (1), 1-12, 2007 | 104 | 2007 |
| The application of high-throughput screening to novel lead discovery S Ren, EJ Lien, NC Turner, JC Clapham, L Prokai, RTE Wagey, C Krieger, ... Progress in drug research, 245-269, 1998 | 103 | 1998 |
| Brain-targeted delivery of a leucine-enkephalin analogue by retrometabolic design K Prokai-Tatrai, L Prokai, N Bodor Journal of medicinal chemistry 39 (24), 4775-4782, 1996 | 99 | 1996 |
| Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs AG Lacko, M Nair, L Prokai, WJ McConathy Expert opinion on drug delivery 4 (6), 665-675, 2007 | 98 | 2007 |
